347 related articles for article (PubMed ID: 30270098)
21. Establishment and validation of two nomograms to predict the benefit of concurrent chemotherapy in stage II-IVa nasopharyngeal carcinoma patients with different risk factors: Analysis based on a large cohort.
Sun XS; Xiao BB; Lin C; Liu SL; Chen QY; Tang LQ; Mai HQ
Cancer Med; 2020 Mar; 9(5):1661-1670. PubMed ID: 31925942
[TBL] [Abstract][Full Text] [Related]
22. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
[TBL] [Abstract][Full Text] [Related]
23. Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Pan XB; Liu Y; Li L; Qu S; Chen L; Liang SX; Chen KH; Liang ZG; Zhu XD
Aging (Albany NY); 2020 Jan; 12(2):1857-1866. PubMed ID: 32005029
[TBL] [Abstract][Full Text] [Related]
24. A nomogram for predicting survival of nasopharyngeal carcinoma patients with metachronous metastasis.
Zeng Z; Shen L; Wang Y; Shi F; Chen C; Wu M; Bai Y; Pan C; Xia Y; Wu P; Li W
Medicine (Baltimore); 2016 Jul; 95(27):e4026. PubMed ID: 27399084
[TBL] [Abstract][Full Text] [Related]
25. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
[TBL] [Abstract][Full Text] [Related]
26. A nomogram for predicting late radiation-induced xerostomia among locoregionally advanced nasopharyngeal carcinoma in intensity modulated radiation therapy era.
Yang K; Xie W; Zhang X; Wang Y; Shou A; Wang Q; Tian J; Yang J; Li G
Aging (Albany NY); 2021 Jul; 13(14):18645-18657. PubMed ID: 34282056
[TBL] [Abstract][Full Text] [Related]
27. Prognosis of nasopharyngeal carcinoma with insufficient radical dose to the primary site in the intensity-modulated radiotherapy era.
Lu T; Xie X; Guo Q; Zhan S; Lin C; Lin S; Zhang Y; Zong J; Pan J
Head Neck; 2019 Oct; 41(10):3516-3524. PubMed ID: 31313419
[TBL] [Abstract][Full Text] [Related]
28. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
29. Dosimetric predictors of temporal lobe injury after intensity-modulated radiotherapy for T4 nasopharyngeal carcinoma: a competing risk study.
Huang J; Kong FF; Oei RW; Zhai RP; Hu CS; Ying HM
Radiat Oncol; 2019 Feb; 14(1):31. PubMed ID: 30736809
[TBL] [Abstract][Full Text] [Related]
30. Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.
Zeng L; Guo P; Li JG; Han F; Li Q; Lu Y; Deng XW; Zhang QY; Lu TX
Oncotarget; 2015 Nov; 6(36):39373-83. PubMed ID: 26415223
[TBL] [Abstract][Full Text] [Related]
31. Stage-dependent conditional survival and failure hazard of non-metastatic nasopharyngeal carcinoma after intensity-modulated radiation therapy: Clinical implications for treatment strategies and surveillance.
Wang J; Huang X; Sun S; Wang K; Qu Y; Chen X; Wu R; Zhang Y; Liu Q; Zhang J; Luo J; Xiao J; Gao L; Xu G; Hu C; Li YX; Yi J
Cancer Med; 2021 Jun; 10(11):3613-3621. PubMed ID: 33960136
[TBL] [Abstract][Full Text] [Related]
32. Pretreatment prognostic factors of survival and late toxicities for patients with nasopharyngeal carcinoma treated by simultaneous integrated boost intensity-modulated radiotherapy.
Lin YH; Huang TL; Chien CY; Chen HC; Hsu HC; Huang EY; Wang CJ; Huang YJ; Wang YM; Huang CC; Chou SY; Liao KC; Fang FM
Radiat Oncol; 2018 Mar; 13(1):45. PubMed ID: 29554940
[TBL] [Abstract][Full Text] [Related]
33. Intensity-modulated radiotherapy for elderly patients with nasopharyngeal carcinoma.
Cao C; Hu Q; Chen X
Head Neck; 2018 Mar; 40(3):590-595. PubMed ID: 29155480
[TBL] [Abstract][Full Text] [Related]
34. Nomograms for predicting survival outcomes in intensity-modulated radiotherapy era of nasopharyngeal carcinoma: A study based on Epstein-Barr virus DNA biological responses.
Yang K; Li M; Zhu J; Zeng L; Tian J; Xie W; Shou A; Li Y; Li G
Head Neck; 2021 Jun; 43(6):1838-1847. PubMed ID: 33605501
[TBL] [Abstract][Full Text] [Related]
35. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
36. Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection.
Li X; Lin C; Yan J; Chen Q; Sun X; Liu S; Guo S; Liu L; Xie H; Tang Q; Liang Y; Guo L; Li H; Liu X; Guo X; Tang L; Mai H
Cancer Biol Med; 2020 Feb; 17(1):227-236. PubMed ID: 32296590
[No Abstract] [Full Text] [Related]
37. Tumor residue in patients with stage II-IVA nasopharyngeal carcinoma who received intensity-modulated radiation therapy: development and validation of a prediction nomogram integrating postradiotherapy plasma Epstein-Barr virus deoxyribonucleic acid, clinical stage, and radiotherapy dose.
Huang YY; Zhou JY; Zhan ZJ; Ke LR; Xia WX; Cao X; Cai ZC; Deng Y; Chen X; Zhang LL; Huang HY; Guo X; Lv X
BMC Cancer; 2023 May; 23(1):410. PubMed ID: 37149594
[TBL] [Abstract][Full Text] [Related]
38. A nomogram for the prediction of cerebrovascular disease among patients with brain necrosis after radiotherapy for nasopharyngeal carcinoma.
Cai J; Cheng J; Li H; Lin WJ; Li Y; Zhuo X; Huang X; Simone CB; Aronow WS; Chow ELW; Tang Y
Radiother Oncol; 2019 Mar; 132():34-41. PubMed ID: 30825967
[TBL] [Abstract][Full Text] [Related]
39. Development and external validation of nomograms to predict the risk of skeletal metastasis at the time of diagnosis and skeletal metastasis-free survival in nasopharyngeal carcinoma.
Yang L; Xia L; Wang Y; He S; Chen H; Liang S; Peng P; Hong S; Chen Y
BMC Cancer; 2017 Sep; 17(1):628. PubMed ID: 28874126
[TBL] [Abstract][Full Text] [Related]
40. A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.
Lai C; Zhang C; Lv H; Huang H; Ke X; Zhou C; Chen H; Chen S; Zhou L
Cancer Med; 2021 Jun; 10(11):3511-3523. PubMed ID: 33973727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
